SCHEMBL5317824

SCHEMBL5317824

OCCCCc1nn(Cc2ccc(F)cc2F)c2cc(C(F)(F)F)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 2/20 0.39
AKR1B1 P15121 2/20 0.37
PTGER4 P35408 1/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC7 Q8WUI4 1/20 0.35
PKM P14618 1/20 0.35
PKLR P30613 1/20 0.35
NTRK1 P04629 3/20 0.34
NTRK3 Q16288 1/20 0.34
NTRK2 Q16620 1/20 0.34
PTGER1 P34995 1/20 0.34
PTGDR2 Q9Y5Y4 5/20 0.33
TBXAS1 P24557 1/20 0.33
VNN1 O95497 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C8 P10632 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316868 0.99 KCNK3 (0.38) KCNK3AKR1B1PTGER4HDAC1HDAC7
SCHEMBL5316520 0.97 KCNK3 (0.39) KCNK3AKR1B1PTGER4HDAC1HDAC7
SCHEMBL5323061 0.93 KCNK3 (0.40) KCNK3AKR1B1PTGER4PKMPKLR
SCHEMBL5322373 0.90 NR1H2 (0.41) RXRANR1H2NR1H3
SCHEMBL5318908 0.90 NR1H2 (0.42) AKR1B1PTGER4PKMPKLRVNN1
SCHEMBL5273263 0.89 NR1H2 (0.41) AKR1B1PTGER4PKMPKLRVNN1
SCHEMBL5322327 0.89 NR1H2 (0.41) RXRANR1H2NR1H3
SCHEMBL5318039 0.88 AKR1B1 (0.43) KCNK3AKR1B1PTGER4HDAC1HDAC7
SCHEMBL1049970 0.88 KCNK3 (0.41) KCNK3AKR1B1PTGER4PKMPKLR
SCHEMBL5320464 0.88 AKR1B1 (0.45) KCNK3AKR1B1PTGER4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed